Flputnam Investment Management Co. Takes Position in iShares Biotechnology ETF (NASDAQ:IBB)

Flputnam Investment Management Co. purchased a new stake in iShares Biotechnology ETF (NASDAQ:IBB) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 1,502 shares of the financial services provider’s stock, valued at approximately $204,000.

Other institutional investors have also recently bought and sold shares of the company. Jacobi Capital Management LLC lifted its stake in iShares Biotechnology ETF by 3.7% in the 3rd quarter. Jacobi Capital Management LLC now owns 2,539 shares of the financial services provider’s stock worth $310,000 after acquiring an additional 91 shares in the last quarter. Geneos Wealth Management Inc. boosted its holdings in shares of iShares Biotechnology ETF by 16.7% during the third quarter. Geneos Wealth Management Inc. now owns 644 shares of the financial services provider’s stock worth $79,000 after purchasing an additional 92 shares during the period. PFG Investments LLC grew its position in iShares Biotechnology ETF by 4.8% during the third quarter. PFG Investments LLC now owns 2,013 shares of the financial services provider’s stock valued at $246,000 after purchasing an additional 93 shares in the last quarter. Huntington National Bank increased its stake in iShares Biotechnology ETF by 7.4% in the 3rd quarter. Huntington National Bank now owns 1,450 shares of the financial services provider’s stock valued at $177,000 after buying an additional 100 shares during the period. Finally, Sovereign Financial Group Inc. increased its stake in iShares Biotechnology ETF by 1.5% in the 4th quarter. Sovereign Financial Group Inc. now owns 6,861 shares of the financial services provider’s stock valued at $901,000 after buying an additional 100 shares during the period. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

Shares of NASDAQ:IBB opened at $124.64 on Friday. The firm has a fifty day moving average of $135.29 and a two-hundred day moving average of $129.51. iShares Biotechnology ETF has a 12-month low of $111.83 and a 12-month high of $141.16.

iShares Biotechnology ETF Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, March 27th. Investors of record on Friday, March 22nd were given a dividend of $0.126 per share. The ex-dividend date was Thursday, March 21st. This represents a $0.50 dividend on an annualized basis and a yield of 0.40%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.